Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $15,043 | 798 | 99.6% |
| Education | $57.53 | 7 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $1,812 | 132 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,615 | 61 | $0 (2024) |
| ABBVIE INC. | $1,110 | 79 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $1,043 | 57 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $889.45 | 48 | $0 (2024) |
| Amgen Inc. | $860.11 | 29 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $723.44 | 21 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $681.07 | 23 | $0 (2024) |
| Lilly USA, LLC | $671.65 | 49 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $670.50 | 31 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,447 | 164 | AstraZeneca Pharmaceuticals LP ($542.58) |
| 2023 | $2,053 | 113 | Bayer Healthcare Pharmaceuticals Inc. ($423.59) |
| 2022 | $933.38 | 59 | Bayer HealthCare Pharmaceuticals Inc. ($185.39) |
| 2021 | $1,003 | 69 | PFIZER INC. ($175.81) |
| 2020 | $1,652 | 110 | PFIZER INC. ($309.65) |
| 2019 | $2,379 | 102 | PFIZER INC. ($477.97) |
| 2018 | $1,705 | 91 | Amarin Pharma Inc. ($276.79) |
| 2017 | $1,928 | 97 | PFIZER INC. ($469.27) |
All Payment Transactions
805 individual payment records from CMS Open Payments — Page 1 of 33
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $27.25 | General |
| Category: Oncology | ||||||
| 12/17/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $8.76 | General |
| Category: Endocrinology | ||||||
| 12/14/2024 | OPKO Pharmaceuticals, LLC | RAYALDEE (Drug) | Education | In-kind items and services | $17.22 | General |
| Category: NEPHROLOGY | ||||||
| 12/12/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $21.45 | General |
| Category: Diabetes | ||||||
| 12/10/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $17.69 | General |
| Category: Cardio-renal | ||||||
| 12/04/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $21.12 | General |
| Category: Inflammation | ||||||
| 12/02/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $17.82 | General |
| Category: Endocrinology | ||||||
| 11/27/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $21.86 | General |
| Category: Neuroscience | ||||||
| 11/25/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $8.03 | General |
| Category: Inflammation | ||||||
| 11/21/2024 | Optinose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $108.30 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 11/21/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $21.03 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/19/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $21.24 | General |
| Category: Cardio-renal | ||||||
| 11/15/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $5.00 | General |
| Category: NEUROSCIENCE | ||||||
| 11/15/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $1.67 | General |
| Category: NEUROSCIENCE | ||||||
| 11/14/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $17.51 | General |
| Category: Endocrinology | ||||||
| 11/14/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $7.44 | General |
| Category: NEUROSCIENCE | ||||||
| 11/12/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $21.15 | General |
| Category: Diabetes | ||||||
| 11/11/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $16.89 | General |
| Category: Diabetes | ||||||
| 11/09/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $21.45 | General |
| Category: Oncology | ||||||
| 11/06/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $14.78 | General |
| Category: RESPIRATORY | ||||||
| 11/04/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $19.99 | General |
| Category: Cardio-renal | ||||||
| 11/04/2024 | Abbott Laboratories | FREESTYLE LIBRE 2 (Device) | Food and Beverage | In-kind items and services | $14.34 | General |
| Category: Diabetes Care | ||||||
| 11/04/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Education | In-kind items and services | $4.22 | General |
| Category: Cardio-renal | ||||||
| 10/29/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.06 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/25/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $15.29 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 253 | 594 | $65,568 | $36,873 |
| 2022 | 9 | 356 | 750 | $164,859 | $56,244 |
| 2021 | 9 | 388 | 853 | $178,203 | $67,754 |
| 2020 | 12 | 555 | 1,030 | $190,032 | $67,079 |
All Medicare Procedures & Services
35 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 164 | 492 | $49,825 | $34,374 | 69.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 13 | 13 | $3,055 | $820.48 | 26.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 43 | 44 | $10,604 | $784.35 | 7.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 12 | 12 | $1,424 | $513.10 | 36.0% |
| 99406 | Smoking and tobacco use intensive counseling, 4-10 minutes | Facility | 2023 | 21 | 33 | $660.00 | $380.49 | 57.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 160 | 540 | $130,223 | $45,042 | 34.6% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2022 | 52 | 53 | $16,483 | $3,653 | 22.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 16 | 16 | $5,184 | $2,061 | 39.8% |
| 90732 | Pneumococcal vaccine, 23-valent | Office | 2022 | 15 | 15 | $4,149 | $1,971 | 47.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 15 | 15 | $5,625 | $1,245 | 22.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 46 | 48 | $1,200 | $1,179 | 98.2% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 19 | 19 | $475.00 | $467.50 | 98.4% |
| 99406 | Smoking and tobacco use intensive counseling, 4-10 minutes | Office | 2022 | 17 | 28 | $1,120 | $422.43 | 37.7% |
| 90471 | Administration of vaccine | Office | 2022 | 16 | 16 | $400.00 | $203.36 | 50.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 187 | 633 | $145,623 | $56,872 | 39.1% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 44 | 45 | $12,079 | $2,928 | 24.2% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 28 | 28 | $10,126 | $2,829 | 27.9% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2021 | 12 | 17 | $2,015 | $1,493 | 74.1% |
| 90732 | Vaccine for pneumococcal polysaccharide for injection beneath the skin or into muscle, patient 2 years or older | Office | 2021 | 11 | 11 | $3,042 | $1,385 | 45.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 50 | 52 | $1,300 | $841.40 | 64.7% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2021 | 12 | 14 | $2,198 | $576.52 | 26.2% |
| 99406 | Smoking and tobacco use intermediate counseling, greater than 3 minutes up to 10 minutes | Office | 2021 | 24 | 33 | $1,320 | $505.23 | 38.3% |
| G0009 | Administration of pneumococcal vaccine | Office | 2021 | 20 | 20 | $500.00 | $323.80 | 64.8% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 187 | 610 | $133,590 | $44,362 | 33.2% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2020 | 63 | 72 | $8,532 | $5,568 | 65.3% |
About Dr. Harold Brown, DO
Dr. Harold Brown, DO is a Family Medicine healthcare provider based in Ontario, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/13/2005. The National Provider Identifier (NPI) number assigned to this provider is 1760486294.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Harold Brown, DO has received a total of $15,100 in payments from pharmaceutical and medical device companies, with $3,447 received in 2024. These payments were reported across 805 transactions from 48 companies. The most common payment nature is "Food and Beverage" ($15,043).
As a Medicare-enrolled provider, Brown has provided services to 1,552 Medicare beneficiaries, totaling 3,227 services with total Medicare billing of $227,950. Data is available for 4 years (2020–2023), covering 35 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Ontario, OH
- Active Since 06/13/2005
- Last Updated 12/07/2020
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1760486294
Products in Payments
- Kerendia (Drug) $889.45
- ENTRESTO (Drug) $642.52
- UBRELVY (Drug) $627.29
- FARXIGA (Drug) $573.35
- XIFAXAN (Drug) $557.19
- Vascepa (Drug) $512.68
- CHANTIX (Drug) $506.02
- ELIQUIS (Drug) $498.54
- VRAYLAR (Drug) $460.15
- LEQVIO (Drug) $400.47
- EUCRISA (Drug) $344.36
- Repatha (Biological) $331.01
- Korlym (Drug) $323.31
- XARELTO (Drug) $317.07
- BEVESPI AEROSPHERE (Drug) $291.61
- LYRICA (Drug) $289.36
- Otezla (Drug) $286.64
- Ozempic (Drug) $279.52
- TRELEGY ELLIPTA (Drug) $275.78
- BREZTRI (Drug) $273.60
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Ontario
Renu Bhupathy, M.d, M.D
Family Medicine — Payments: $18,525
Dr. Gordon Long, M.d, M.D
Family Medicine — Payments: $14,963
Edward Adkins, M.d, M.D
Family Medicine — Payments: $14,470
Melissa Becker, Md, MD
Family Medicine — Payments: $5,465
Dr. Charles Ho, M.d, M.D
Family Medicine — Payments: $2,949
Judith Cabrera, Md, MD
Family Medicine — Payments: $2,574